Amlodipine And Valsartan
Product Images NDC 50090-2471

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 50090-2471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Amlodipine Valsartan 01)

A line graph comparing the percentage of patients with systolic blood pressure (SBP) below 140 mmHg against baseline SBP (mmHg) for four groups: Amlodipine and Valsartan 10/320 mg combination, Valsartan 320 mg, Amlodipine 10 mg, and placebo. The graph shows higher efficacy with the combination treatment, followed by individual agents and placebo.*

FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Amlodipine Valsartan 02)

A line graph comparing the percentage of patients with diastolic blood pressure (DBP) below 90 mmHg against baseline DBP measurements (mmHg). It includes four curves representing Amlodipine and Valsartan 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo groups.*

FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Amlodipine Valsartan 03)

A line graph comparing the percentage of systolic blood pressure (SBP) under 130 mmHg against baseline SBP in mmHg for four groups: Amlodipine/Val 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo. The graph shows the highest percentage for the combination Amlodipine/Val 10/320 mg and the lowest for placebo, across baseline SBP values from 140 to 180 mmHg.*

FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Amlodipine Valsartan 04)

A line chart showing the percentage of subjects with diastolic blood pressure (DBP) under 80 mmHg, plotted against baseline DBP in mmHg. The graph compares four groups: Amlodipine/valsartan 10/320 mg, valsartan 320 mg, amlodipine 10 mg, and placebo, with Amlodipine/valsartan showing the highest percentage achieving DBP <80 mmHg across baseline values.*

FDA Label Image

Amlodipine Besylate Structural Formula (Amlodipine Valsartan 05)

Chemical structure diagram showing molecular formulas, including a chlorophenyl group, ester, sulfonic acid, and amine groups. The structure depicts components consistent with multiple active ingredients, possibly related to amlodipine and valsartan.*

FDA Label Image

Valsartan Structural Formula (Amlodipine Valsartan 06)

Chemical structure of amlodipine and valsartan, showing the molecular configuration with labeled functional groups and stereochemistry as depicted in the image.*

FDA Label Image

Label Image (Lbl500902471)

Packaging label for AMLODIPINE AND VALSARTAN, containing 30 tablets. Each tablet contains amlodipine besylate equivalent to 5 mg amlodipine and valsartan 320 mg. Distributed by ASM Medication Solutions, Libertyville, IL, 60048. Storage instructions indicate to store at 77 degrees F and protect from moisture.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.